Literature DB >> 10478846

Androgen specificity of a response unit upstream of the human secretory component gene is mediated by differential receptor binding to an essential androgen response element.

G Verrijdt1, E Schoenmakers, P Alen, A Haelens, B Peeters, W Rombauts, F Claessens.   

Abstract

The expression of secretory component (SC), the epithelial receptor for poly-immunoglobulins, is regulated in a highly tissue-specific manner. In several tissues, e.g. lacrimal gland and prostate, SC synthesis is enhanced by androgens at the transcriptional level. In this study, we describe the presence of an androgen response unit, located 3.3 kb upstream of the sc transcription initiation site and containing several 5'-TGTTCT-3'-like motifs. Although each of these elements is implicated in the enhancer function, one element, the ARE1.2 motif, is found to be the main interaction site for the androgen receptor as demonstrated in in vitro binding assays as well as in transient transfection assays. A high-affinity binding site for nuclear factor I, adjacent to this ARE, is also involved in the correct functioning of the sc upstream enhancer. The ARE1.2 motif consists of an imperfect direct repeat of two core binding elements with a three-nucleotide spacer and therefore constitutes a nonconventional ARE. We demonstrate that this element displays selectivity for the androgen receptor as opposed to glucocorticoid receptor both in in vitro binding assays and in transfection experiments. Mutational analysis suggests that the direct nature of the half-site repeat is responsible for this selectivity. We have thus determined a complex and androgen-specific response unit in the far upstream region of the human SC gene, which we believe to be involved in its androgen responsiveness in epithelial cells of different organs such as prostate and lacrimal gland. We were also able to demonstrate that the primary sequence of a single nonconventional ARE motif within the enhancer is responsible for its androgen specificity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10478846     DOI: 10.1210/mend.13.9.0347

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  22 in total

1.  DNA recognition by the androgen receptor: evidence for an alternative DNA-dependent dimerization, and an active role of sequences flanking the response element on transactivation.

Authors:  Annemie Haelens; Guy Verrijdt; Leen Callewaert; Valerie Christiaens; Kris Schauwaers; Ben Peeters; Wilfried Rombauts; Frank Claessens
Journal:  Biochem J       Date:  2003-01-01       Impact factor: 3.857

2.  Characterization of cis elements of the probasin promoter necessary for prostate-specific gene expression.

Authors:  JianFeng Zhang; Nan Gao; David J DeGraff; Xiuping Yu; Qian Sun; Thomas C Case; Susan Kasper; Robert J Matusik
Journal:  Prostate       Date:  2010-06-15       Impact factor: 4.104

3.  Analysis of glucocorticoid and androgen receptor gene fusions delineates domains required for transcriptional specificity.

Authors:  D C Whitacre; K J Karnas; R L Miesfeld
Journal:  Endocrine       Date:  2001-06       Impact factor: 3.633

Review 4.  The androgen receptor and its use in biological assays: looking toward effect-based testing and its applications.

Authors:  Amy B Cadwallader; Carol S Lim; Douglas E Rollins; Francesco Botrè
Journal:  J Anal Toxicol       Date:  2011-11       Impact factor: 3.367

5.  Androgen-induced activation of gonadotropin-regulated testicular RNA helicase (GRTH/Ddx25) transcription: essential role of a nonclassical androgen response element half-site.

Authors:  Joaquin Villar; Chon-Hwa Tsai-Morris; Lisheng Dai; Maria L Dufau
Journal:  Mol Cell Biol       Date:  2012-02-13       Impact factor: 4.272

6.  The rules of DNA recognition by the androgen receptor.

Authors:  Sarah Denayer; Christine Helsen; Lieven Thorrez; Annemie Haelens; Frank Claessens
Journal:  Mol Endocrinol       Date:  2010-03-19

7.  Differential regulation of LncRNA-SARCC suppresses VHL-mutant RCC cell proliferation yet promotes VHL-normal RCC cell proliferation via modulating androgen receptor/HIF-2α/C-MYC axis under hypoxia.

Authors:  W Zhai; Y Sun; M Jiang; M Wang; T A Gasiewicz; J Zheng; C Chang
Journal:  Oncogene       Date:  2016-03-14       Impact factor: 9.867

8.  Nuclear factor-kappaB contributes to interleukin-4- and interferon-dependent polymeric immunoglobulin receptor expression in human intestinal epithelial cells.

Authors:  Laynez W Ackermann; Gerene M Denning
Journal:  Immunology       Date:  2004-01       Impact factor: 7.397

9.  The Role of Androgen Receptor in Breast Cancer.

Authors:  Domenico Iacopetta; Yassine Rechoum; Suzanne Aw Fuqua
Journal:  Drug Discov Today Dis Mech       Date:  2012

10.  Manipulating prohibitin levels provides evidence for an in vivo role in androgen regulation of prostate tumours.

Authors:  D Alwyn Dart; Bradley Spencer-Dene; Simon C Gamble; Jonathan Waxman; Charlotte L Bevan
Journal:  Endocr Relat Cancer       Date:  2009-07-27       Impact factor: 5.678

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.